A humanized mouse model to study asthmatic airway inflammation via the human IL-33/IL-13 axis.

Asthma is one of the most common immunological diseases and is characterized by airway hyperresponsiveness (AHR), mucus overproduction, and airway eosinophilia. Although mouse models have provided insight into the mechanisms by which type-2 cytokines induce asthmatic airway inflammation, differences between the rodent and human immune systems hamper efforts to improve understanding of human allergic diseases. In this study, we aim to establish a preclinical animal model of asthmatic airway inflammation using humanized IL-3/GM-CSF or IL-3/GM-CSF/IL-5 Tg NOD/Shi-scid-IL2rγnull (NOG) mice and investigate the roles of human type-2 immune responses in the asthmatic mice. Several important characteristics of asthma - such as AHR, goblet cell hyperplasia, T cell infiltration, IL-13 production, and periostin secretion - were induced in IL-3/GM-CSF Tg mice by intratracheally administered human IL-33. In addition to these characteristics, human eosinophilic inflammation was observed in IL-3/GM-CSF/IL-5 Tg mice. The asthmatic mechanisms of the humanized mice were driven by activation of human Th2 and mast cells by IL-33 stimulation. Furthermore, treatment of the humanized mice with an anti-human IL-13 antibody significantly suppressed these characteristics. Therefore, the humanized mice may enhance our understanding of the pathophysiology of allergic disorders and facilitate the preclinical development of new therapeutics for IL-33-mediated type-2 inflammation in asthma.

[1]  R. Ito,et al.  A novel in vivo model for predicting myelotoxicity of chemotherapeutic agents using IL-3/GM-CSF transgenic humanized mice. , 2017, Toxicology letters.

[2]  K. Izuhara,et al.  Periostin in inflammation and allergy , 2017, Cellular and Molecular Life Sciences.

[3]  H. Ichijo,et al.  Involvement of apoptosis signal-regulating kinase-1 in house dust mite-induced allergic asthma in mice. , 2017, Allergology international : official journal of the Japanese Society of Allergology.

[4]  G. Freeman,et al.  Type 2 innate lymphoid cell suppression by regulatory T cells attenuates airway hyperreactivity and requires inducible T‐cell costimulator–inducible T‐cell costimulator ligand interaction , 2017, The Journal of allergy and clinical immunology.

[5]  G. Canonica,et al.  Reslizumab and Eosinophilic Asthma: One Step Closer to Precision Medicine? , 2017, Front. Immunol..

[6]  I. Amit,et al.  Systemic Human ILC Precursors Provide a Substrate for Tissue ILC Differentiation , 2017, Cell.

[7]  G. Canonica,et al.  A Critical Evaluation of Anti-IL-13 and Anti-IL-4 Strategies in Severe Asthma , 2016, International Archives of Allergy and Immunology.

[8]  E. R. Sutherland,et al.  Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial , 2016, The Lancet.

[9]  Ying Sun,et al.  Interleukin (IL)‐25: Pleiotropic roles in asthma , 2016, Respirology.

[10]  K. Izuhara,et al.  Periostin promotes hepatic fibrosis in mice by modulating hepatic stellate cell activation via αv integrin interaction , 2016, Journal of Gastroenterology.

[11]  Marcus Maurer,et al.  The role of IL-33 and mast cells in allergy and inflammation , 2015, Clinical and Translational Allergy.

[12]  M. Wills-Karp,et al.  IL-4 and IL-13 signaling in allergic airway disease. , 2015, Cytokine.

[13]  Z. Modrušan,et al.  IL-13 mediates IL-33-dependent mast cell and type 2 innate lymphoid cell effects on bronchial epithelial cells. , 2015, The Journal of allergy and clinical immunology.

[14]  Richard J Martin,et al.  Persistence of asthma requires multiple feedback circuits involving type 2 innate lymphoid cells and IL-33. , 2015, The Journal of allergy and clinical immunology.

[15]  A. Klion,et al.  Biologic therapies targeting eosinophils: current status and future prospects. , 2015, The journal of allergy and clinical immunology. In practice.

[16]  L. Graham,et al.  The impact of asthma exacerbations and preventive strategies , 2015, Current medical research and opinion.

[17]  S. Akthar,et al.  Alternaria-derived serine protease activity drives IL-33–mediated asthma exacerbations , 2014, The Journal of allergy and clinical immunology.

[18]  K. Acharya,et al.  Eosinophil Granule Proteins: Form and Function , 2014, The Journal of Biological Chemistry.

[19]  T. Nabe,et al.  IL-17A Promotes the Exacerbation of IL-33–Induced Airway Hyperresponsiveness by Enhancing Neutrophilic Inflammation via CXCR2 Signaling in Mice , 2014, The Journal of Immunology.

[20]  T. Betsuyaku,et al.  Thymic stromal lymphopoietin induces corticosteroid resistance in natural helper cells during airway inflammation , 2013, Nature Communications.

[21]  H. Suemizu,et al.  Establishment of a Human Allergy Model Using Human IL-3/GM-CSF–Transgenic NOG Mice , 2013, The Journal of Immunology.

[22]  S. Wenzel,et al.  Dupilumab in persistent asthma with elevated eosinophil levels. , 2013, The New England journal of medicine.

[23]  H. Suemizu,et al.  Efficient Xenoengraftment in Severe Immunodeficient NOD/Shi-scid IL2rγnull Mice Is Attributed to a Lack of CD11c+B220+CD122+ Cells , 2012, The Journal of Immunology.

[24]  James J. Lee,et al.  Human versus mouse eosinophils: "that which we call an eosinophil, by any other name would stain as red". , 2012, The Journal of allergy and clinical immunology.

[25]  S. Toda,et al.  Periostin, a matricellular protein, accelerates cutaneous wound repair by activating dermal fibroblasts , 2012, Experimental dermatology.

[26]  Mamoru Ito,et al.  Induction of human humoral immune responses in a novel HLA-DR-expressing transgenic NOD/Shi-scid/γcnull mouse. , 2012, International immunology.

[27]  Mamoru Ito,et al.  Current advances in humanized mouse models , 2012, Cellular and Molecular Immunology.

[28]  Nicola A Hanania,et al.  Lebrikizumab treatment in adults with asthma. , 2011, The New England journal of medicine.

[29]  P. O'Byrne.  Therapeutic strategies to reduce asthma exacerbations. , 2011, The Journal of allergy and clinical immunology.

[30]  S. Nakae,et al.  IL-33 and Airway Inflammation , 2011, Allergy, asthma & immunology research.

[31]  C. Lloyd,et al.  Functions of T cells in asthma: more than just TH2 cells , 2010, Nature Reviews Immunology.

[32]  S. Hopkinson,et al.  Faculty Opinions recommendation of Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. , 2010 .

[33]  S. Muller,et al.  Roles of epithelial cell-derived periostin in TGF-β activation, collagen production, and collagen gel elasticity in asthma , 2010, Proceedings of the National Academy of Sciences.

[34]  G. Colice,et al.  Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol. , 2009, Clinical therapeutics.

[35]  Barmak Modrek,et al.  T-helper type 2-driven inflammation defines major subphenotypes of asthma. , 2009, American journal of respiratory and critical care medicine.

[36]  Mamoru Ito,et al.  The analysis of the functions of human B and T cells in humanized NOD/shi-scid/gammac(null) (NOG) mice (hu-HSC NOG mice). , 2009, International immunology.

[37]  H. Hammad,et al.  House dust mite allergen induces asthma via Toll-like receptor 4 triggering of airway structural cells , 2009, Nature Medicine.

[38]  S. Wenzel,et al.  Tissue and BAL based biomarkers in asthma. , 2007, Immunology and allergy clinics of North America.

[39]  P. Sly,et al.  Animal models of asthma , 2007, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[40]  S. Holgate,et al.  The mechanisms, diagnosis, and management of severe asthma in adults , 2006, The Lancet.

[41]  S. Peters,et al.  Uncontrolled asthma: a review of the prevalence, disease burden and options for treatment. , 2006, Respiratory medicine.

[42]  S. Toda,et al.  Periostin: a novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals. , 2006, The Journal of allergy and clinical immunology.

[43]  M. Jordana,et al.  House dust mite facilitates ovalbumin-specific allergic sensitization and airway inflammation. , 2005, American journal of respiratory and critical care medicine.

[44]  M. Kotb,et al.  Human Lymphoid and Myeloid Cell Development in NOD/LtSz-scid IL2Rγnull Mice Engrafted with Mobilized Human Hemopoietic Stem Cells 12 , 2004, The Journal of Immunology.

[45]  P. Sly,et al.  The pattern of methacholine responsiveness in mice is dependent on antigen challenge dose , 2004, Respiratory research.

[46]  Markus G. Manz,et al.  Development of a Human Adaptive Immune System in Cord Blood Cell-Transplanted Mice , 2004, Science.

[47]  D. Broide,et al.  Inhibition of airway remodeling in IL-5-deficient mice. , 2004, The Journal of clinical investigation.

[48]  R. E. Wiley,et al.  Continuous exposure to house dust mite elicits chronic airway inflammation and structural remodeling. , 2004, American journal of respiratory and critical care medicine.

[49]  N. Lukacs,et al.  Interleukin-12-independent down-modulation of cockroach antigen-induced asthma in mice by intranasal exposure to bacterial lipopolysaccharide. , 2003, The American journal of pathology.

[50]  S. Phipps,et al.  Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. , 2003, The Journal of clinical investigation.

[51]  Mamoru Ito,et al.  NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells. , 2002, Blood.

[52]  J. Renauld.  New insights into the role of cytokines in asthma , 2001, Journal of clinical pathology.

[53]  T. Mosmann,et al.  Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells. , 1999, Journal of immunology.

[54]  M. van de Rijn,et al.  Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Miyazaki,et al.  Defective B-1 cell development and impaired immunity against Angiostrongylus cantonensis in IL-5R alpha-deficient mice. , 1996, Immunity.

[56]  伊藤 亮治.  Efficient xenoengraftment in severe immunodeficient NOD/Shi-scid IL2rγ[null] mice is attributed to a lack of CD11c⁺B220⁺CD122⁺ cells , 2013 .

[57]  M. Harada,et al.  The differentiative and regenerative properties of human hematopoietic stem/progenitor cells in NOD-SCID/IL2rgamma(null) mice. , 2008, Current topics in microbiology and immunology.

[58]  T. Nakahata,et al.  NOD/Shi-scid IL2rgamma(null) (NOG) mice more appropriate for humanized mouse models. , 2008, Current topics in microbiology and immunology.

[59]  M. Fan,et al.  Role of adenosine in airway inflammation in an allergic mouse model of asthma. , 2006, International immunopharmacology.